Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer

Skeletal metastases from thyroid cancer are poorly responsive to medical or radioiodine treatment. Bone destruction in skeletal metastases results from osteoclast-induced bone resorption. Therefore, a new approach in the therapy of bone metastases consists in using aminobisphosphonates, such as pami...

Descripción completa

Detalles Bibliográficos
Autores principales: Vitale, G, Fonderico, F, Martignetti, A, Caraglia, M, Ciccarelli, A, Nuzzo, V, Abbruzzese, A, Lupoli, G
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363684/
https://www.ncbi.nlm.nih.gov/pubmed/11401309
http://dx.doi.org/10.1054/bjoc.2001.1832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363684/
https://www.ncbi.nlm.nih.gov/pubmed/11401309
http://dx.doi.org/10.1054/bjoc.2001.1832

Ejemplares similares